Citation Impact
Citing Papers
Comparison of the Ligand Binding Specificity and Transcript Tissue Distribution of Estrogen Receptors α and β
1997 Standout
Cytotoxic T Lymphocyte Antigen-4 Blockade Enhances Antitumor Immunity by Stimulating Melanoma-Specific T-cell Motility
2014 StandoutNobel
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Recent advances in immunotherapies: from infection and autoimmunity, to cancer, and back again
2018 StandoutNobel
The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications
2020 Standout
Messenger RNA-Based Vaccines Against Infectious Diseases
2020 StandoutNobel
Patient-Reported Impotence and Incontinence After Nerve-Sparing Radical Prostatectomy
1997
Quality of Life and Satisfaction with Outcome among Prostate-Cancer Survivors
2008 Standout
Testosterone Therapy in Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline
2010 Standout
Prediction of Functional Outcomes After Nerve-Sparing Radical Prostatectomy: Results of Conditional Survival Analyses
2012
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
2012 Standout
Lipid nanoparticles for mRNA delivery
2021 Standout
Natural History of Progression After PSA Elevation Following Radical Prostatectomy
1999 Standout
Immunohistochemistry and biochemistry in detection of androgen, progesterone, and estrogen receptors in benign and malignant human prostatic tissue
1992
Lipid nanoparticle chemistry determines how nucleoside base modifications alter mRNA delivery
2021 StandoutNobel
Individualized Estimation of the Benefit of Radical Prostatectomy from the Scandinavian Prostate Cancer Group Randomized Trial
2012
Robot-assisted versus open radical prostatectomy: a comparison of one surgeon's outcomes
2004 StandoutNobel
Nomograms in oncology: more than meets the eye
2015 Standout
Molecular determinants of resistance to antiandrogen therapy
2003 Standout
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs
2021 StandoutNobel
Cancer immunotherapy via dendritic cells
2012 Standout
Vaccination with Messenger RNA: A Promising Alternative to DNA Vaccination
2020 StandoutNobel
Recent advances in mRNA vaccine technology
2020 StandoutNobel
Comparison of Conventional-Dose vs High-Dose Conformal Radiation Therapy in Clinically Localized Adenocarcinoma of the Prostate
2005 Standout
Amniotic fluid stabilized lipid nanoparticles for in utero intra-amniotic mRNA delivery
2021 StandoutNobel
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
Delivery technologies for cancer immunotherapy
2019 Standout
Prospective comparison of radical retropubic prostatectomy and robot-assisted anatomic prostatectomy: The Vattikuti Urology Institute experience
2002
Novel cancer immunotherapy agents with survival benefit: recent successes and next steps
2011 StandoutNobel
Screening for Prostate Cancer with Prostate-Specific Antigen — An Examination of the Evidence
1995
Stage D1 prostate cancer treated by radical prostatectomy and adjuvant hormonal treatment. Evidence for favorable survival in patients with DNA diploid tumors
1992
Cancer immunotherapy comes of age
2011 StandoutNature
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations
2004 Standout
Repertoire Enhancement with Adoptively Transferred Female Lymphocytes Controls the Growth of Pre-Implanted Murine Prostate Cancer
2012 StandoutNobel
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
2015 Standout
Participation Rates in Epidemiologic Studies
2007 Standout
A prospective comparison of radical retropubic and robot‐assisted prostatectomy: experience in one institution
2003
Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery
2019
EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent—Update 2013
2013 Standout
Nanomaterial Delivery Systems for mRNA Vaccines
2021 StandoutNobel
The Response of Metastatic Adenocarcinoma of the Prostate to Exogenous Testosterone
1981
Ionizable Lipid Nanoparticles for In Vivo mRNA Delivery to the Placenta during Pregnancy
2023 StandoutNobel
Orthogonal Design of Experiments for Engineering of Lipid Nanoparticles for mRNA Delivery to the Placenta
2023 StandoutNobel
Estrogen Receptors in Human Prostate: Evidence for Multiple Binding Sites*
1983
Current concepts in the diagnosis and management of cytokine release syndrome
2014 Standout
In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism
2023 StandoutNobel
Cloning of a novel receptor expressed in rat prostate and ovary.
1996 Standout
Metabolic Complications of Androgen Deprivation Therapy for Prostate Cancer
2009
Changing prostate-specific antigen outcome after surgery or radiotherapy for localized prostate cancer during the prostate-specific antigen era
2002
Sexual Function following Radical Prostatectomy: Influence of Preservation of Neurovascular Bundles
1991
Long-Term Results of Retropubic Permanent 125 Iodine Implantation of the Prostate for Clinically Localized Prostatic Cancer
1997
Radical Nephrectomy for pT1a Renal Masses May be Associated With Decreased Overall Survival Compared With Partial Nephrectomy
2008
Cancer treatment and survivorship statistics, 2019
2019 Standout
The pathogenesis of benign prostatic hyperplasia
1980 Standout
FACTORS PREDICTING RECOVERY OF ERECTIONS AFTER RADICAL PROSTATECTOMY
2000 Standout
QUALITY OF LIFE OUTCOMES AFTER BRACHYTHERAPY FOR EARLY STAGE PROSTATE CANCER
2000
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
Up-Regulation of PD-L1, IDO, and T regs in the Melanoma Tumor Microenvironment Is Driven by CD8 + T Cells
2013 Standout
LNCaP model of human prostatic carcinoma.
1983 Standout
Guideline for Management of the Clinical T1 Renal Mass
2009 Standout
Serum PSA after anatomic radical prostatectomy. The Johns Hopkins experience after 10 years.
1993
Information for Decision Making by Patients With Early-Stage Prostate Cancer
2011
Cancer treatment and survivorship statistics, 2014
2014 Standout
Works of Walsh Pc being referenced
The binding of a potent synthetic androgen--methyltrienolone (R 1881)--to cytosol preparations of human prostatic cancer.
1977
Characterization and measurement of androgen receptors in human prostatic tissue.
1979
Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer: a multi-institutional update.
1997
Methods for the determination of androgen receptor content in human prostatic tissue.
1981
Long-term results of radical prostatectomy in clinically localized prostate cancer: experience at the Johns Hopkins Hospital.
1988
A decision analysis of alternative treatment strategies for clinically localized prostate cancer.
1993
Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council trial. The Medical Research Council Prostate Cancer Working Party Investigators Group.
1997
Radical retropubic prostatectomy with reduced morbidity: an anatomic approach.
1988
Expectant management of prostate cancer with curative intent: an update of the Johns Hopkins experience
2007
Preservation of sexual function in the surgical treatment of prostatic cancer--an anatomic surgical approach.
1988